• 1
    Rocha PN, Plumb TJ, Crowley SD, Coffman TM. Effector mechanisms in transplant rejection. Immunol Rev 2003; 196: 5164.
  • 2
    He C, Heeger PS. CD8 T cells can reject Major histocompatibility Complex class I deficient skin allografts. Am J Transplant 2004; 4: 698704.
  • 3
    Melief CJM. Regulation of cytotoxic T lymphocyte responses by dendritic cells: peaceful coexistence of cross-priming and direct priming. Eur J Immunol 2003; 33: 26452654.
  • 4
    Golding H, Singer A. Role of accessory cell processing and presentation of shed H-2 alloantigens in allospecific cytotoxix T lymphocyte responses. J Immunol 1984; 133: 597605.
  • 5
    Kievits F, Ivanyi P. A subpopulation of mouse cytotoxic T lymphocytes recognizes allogeneic H-2 class I antigens in the context of other H-2 class I molecules. J Exp Med 1991; 174: 1519.
  • 6
    Popov IA, Fedoseyeva EV, Orr PL, Garovoy MR, Benichou G. Direct evidence for in vivo induction of CD8+ cytotoxic T cells directed to donor MHC class I peptides following mouse allotransplantation. Transplantation 1995; 60: 16211624.
  • 7
    Valujskikh A, Lantz O, Celli S, Matzinger P, Heeger PS. Cross-primed CD8 T cells mediate graft rejection via a distinct effector pathway. Nat Immunol 2002; 3: 844851.
  • 8
    Pober JS, Is. host endothelium a silver lining for allografts Lancet 2001; 357: 23.